The Role of the AP-1 Transcription Factors c-Fos, FosB, Fra-1 and Fra-2 in the Invasion Process of Mammary Carcinomas (original) (raw)
References
Karin M, Liu Z-G, Zandi E: AP-1 function and regulation. Curr Opin Cell Biol 9: 240–246, 1997 Google Scholar
Ryseck R-P, Bravo R: c-Jun, JunB, JunD differ in their binding affinities to AP-1 and CRE consensus sequences: effect of fos proteins. Oncogene 6: 533–542, 1991 Google Scholar
Mechta F, Lallemand D, Pfarr CM, Yaniv M: Transformation by ras modifies AP-1 composition and activity. Oncogene 14: 837–847, 1997 Google Scholar
Pospelova TV, Medvedev AV, Kukushkin AN, Svetlikova SB, van der Eb AJ, Dorsman JC, Pospelov VA: E1A+cHa-ras transformed rat embryo fibroblast cells are characterized by high and constitutive DNA binding activities of AP-1 dimers with significantly altered composition. Gene expr 8: 19–32, 1999 Google Scholar
Smith LM, Wise SC, Hendricks DT, Sabichi AL, Bos T, Reddy P, Brown PH, Birrer MJ: cjun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene 18: 6063–6070, 1999 Google Scholar
Soto U, Denk C, Finzer P, Hutter KJ, zur Hausen H, Rösl F: Genetic complementation to non-tumorigenicity in cervical-carcinoma cells correlates with alterations in AP-1 composition. Int J Cancer 86: 811–817, 2000 Google Scholar
Vallone D, Battista S, Pierantoni GM, Fedele M, Casalino L, Santoro M, Viglietto G, Fusco A, Verde P: Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J 16: 5310–5321, 1997 Google Scholar
Bamberger A-M, Methner C, Lisboa BW, Städtler C, Schulte HM, Löning T, Milde-Langosch K: Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive phenotype. Int J Cancer 84: 553–558, 1999 Google Scholar
Milde-Langosch K, Bamberger AM, Methner C, Rieck G, Löning T: Expression of cell cycle regulatory proteins Rb, p16/MTS1, p27/Kip1, p21/Waf1, cyclin D1 and cyclin E in breast cancer: correlations with expression of activating protein-1 family members. Int J Cancer 87: 468–472, 2000 Google Scholar
Andersen H, Mahmood S, Tkach V, Cohn M, Kustikova O, Grigorian M, Berezin V, Bock E, Lukanidin E, Tulchinsky E: The ability of Fos family members to produce phenotypic changes in epitheloid cells is not directly linked to their transactivation potentials. Oncogene 21: 4843–4848, 2002 Google Scholar
Nandy A, Jenatschke S, Hartung B, Milde-Langosch K, Bamberger A-M, Gellersen B: Genomic structure and transcriptional regulation of the human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (PGDH) gene. Endocrinology, in press
Lawrence DA, Olson ST, Palaniappan S, Ginsburg D: Serpin reactive center loop mobilityis required for inhibitor function but not for enzyme recognition. J Biol Chem 269: 27657–27662, 1994 Google Scholar
Milde-Langosch K, Kappes H, Riethdorf S, Löning T, Bamberger A-M: FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas. Breast Cancer Res Tr 77: 265–275, 2003 Google Scholar
Kupferman ME, Fini ME, Muller WJ, Weber R, Cheng Y, Muschel RJ: Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol 157: 1777–1783, 2000 Google Scholar
Toi M, Ishigaki S, Tominaga T: Metalloproteinases and tissue inhibitors of metalloproteinases. Breast Cancer Res Treat 52: 113–124, 1998 Google Scholar
Tulchinsky E: Fos family members: regulation, structure and role in oncogenic transformation. Histol Histopathol 15: 921–928, 2000 Google Scholar
Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP, Johnson PH: Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 61: 5168–5178, 2001 Google Scholar
Fung LF, Lo AKF, Yuen PW, Liu Y, Wang XH, Tsao SW: Differential gene expression in nasopharyngeal carcinoma cells. Life Sci 67: 923–936, 2000 Google Scholar
Zoumpourlis V, Papassava P, Linardopoulos S, Gillespie D, Balmain A, Pintzas A: High levels of phosphorylated c-jun, fra-1, fra-2, and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model. Oncogene 19: 4011–4021, 2000 Google Scholar
Kustikova O, Kramerov D, Grigorian M, Berezin V, Bock E, Lukanidin E, Tulchinsky E: Fra-1 induces morphological transformation and increases in vitro invasiveness and mobility of epithelioid adenocarcinoma cells. Mol Cell Biol 18: 7095–7105, 1998 Google Scholar
Friedl P, Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nature Rev 3: 362–374, 2003 Google Scholar
Rudland PS, Platt-Higgins A, El-Tanani M, De Silva Rudland S, Barraclough R, Winstanley JH, Howitt R, West CR: Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res 62: 3417–3427, 2002 Google Scholar
Mechta-Grigoriou F, Gerald D, Yaniv M: The mammalian Jun proteins: redundancy and specificity. Oncogene 20: 2378–2389, 2001 Google Scholar
Rinehart-Kim J, Johnston M, Birrer M, Bos T: Alterations in the gene expression profile of MCF-7 breast tumor cells in response to c-jun. Int J Cancer 88: 180–190, 2000 Google Scholar
Briggs J, Chamboredon S, Castellazzi M, Kerry J-A, Bos T-J: Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells. Oncogene 21: 7077–7091, 2002 Google Scholar